A case of severe liver injury in a patient using ulipristal acetate 5 mg was identified, requiring liver transplantation; there is a real, significant probability of serious harm to health or life. Potential effects: severe liver damage, liver failure, life-threatening complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Esmya (ulipristal acetate) 5 mg; patients currently taking it should contact their physician for further management and liver function assessment.
All batches of the medicinal product Esmya 5 mg were suspended from marketing throughout the country; the decision was given immediate enforceability; the marketing authorisation holder was obliged to...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related